U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
139594
Name Type Language
Glenzocimab
USAN   INN  
Official Name English
Glenzocimab [WHO-DD]
Common Name English
Immunoglobulin Fab G1-kappa, anti-[Homo sapiens GP6 (glycoprotein VI platelet, glycoprotein VI (platelet), GPVI, platelet glycoprotein VI)], humanized monoclonal antibody; gamma1 heavy chain VH-CH1 humanized (1-227) [VH (Homo sapiens IGHV1-46*01 (92.9%)
Common Name English
ACT-017
Code English
GLENZOCIMAB [USAN]
Common Name English
ACT017
Code English
Immunoglobulin G1, anti-(human platetet glycoprotein VI) Fab fragment (humanized monoclonal ACT017 γ1-chain), disulfide with humanized monoclonal ACT017 κ-chain
Common Name English
glenzocimab [INN]
Common Name English
Code System Code Type Description
INN
10956
Created by admin on Sat Dec 16 16:44:44 GMT 2023 , Edited by admin on Sat Dec 16 16:44:44 GMT 2023
PRIMARY
USAN
KL-152
Created by admin on Sat Dec 16 16:44:44 GMT 2023 , Edited by admin on Sat Dec 16 16:44:44 GMT 2023
PRIMARY
NCI_THESAURUS
C166827
Created by admin on Sat Dec 16 16:44:44 GMT 2023 , Edited by admin on Sat Dec 16 16:44:44 GMT 2023
PRIMARY
FDA UNII
58D9BCH9O0
Created by admin on Sat Dec 16 16:44:44 GMT 2023 , Edited by admin on Sat Dec 16 16:44:44 GMT 2023
PRIMARY
CAS
2101829-58-5
Created by admin on Sat Dec 16 16:44:44 GMT 2023 , Edited by admin on Sat Dec 16 16:44:44 GMT 2023
PRIMARY
ACTIVE MOIETY
Glenzocimab
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966